Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Clin Nutr ; 35(1): 225-229, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25660415

RESUMEN

BACKGROUND & AIMS: Exact data on Dutch patients with chronic intestinal failure (CIF) and after intestinal transplantation (ITx) have been lacking. To improve standard care of these patients, a nationwide collaboration has been established. Objectives of this study were obtaining an up-to-date prevalence of CIF and characterizing these patients using the specially developed multicenter web-based Dutch Registry of Intestinal Failure and Intestinal Transplantation (DRIFT). METHODS: Cross-sectional study. CIF was defined as type 3 intestinal failure in which >75% of nutritional requirements were given as home parenteral nutrition (HPN) for ≥ 4 weeks in children and >50% for ≥3 months in adults. All patients with CIF receiving HPN care by the three Dutch specialized centers on January 1, 2013 and all ITx patients were registered in DRIFT (https://drift.darmfalen.nl). RESULTS: In total, 195 patients with CIF (158 adults, 37 children) were identified, of whom 184 were registered in DRIFT. The Dutch point prevalence of CIF was 11.62 per million (12.24 for adults, 9.56 for children) on January 1, 2013. Fifty-seven patients (31%) had one or more indications for ITx, while 12 patients actually underwent ITx since its Dutch introduction. Four patients required transplantectomy of their intestinal graft and 3 intestinal transplant patients died. CONCLUSION: The multicenter registry DRIFT revealed an up-to-date prevalence of CIF and provided nationwide insight into the patients with CIF during HPN and after ITx in the Netherlands. DRIFT will facilitate the multicenter monitoring of individual patients, thereby supporting multidisciplinary care and decision-making.


Asunto(s)
Enfermedades Intestinales/epidemiología , Intestinos/trasplante , Trasplante de Órganos , Sistema de Registros , Adulto , Niño , Enfermedad Crónica , Estudios Transversales , Femenino , Humanos , Internet , Enfermedades Intestinales/cirugía , Intestinos/fisiopatología , Masculino , Países Bajos/epidemiología , Necesidades Nutricionales , Nutrición Parenteral en el Domicilio , Complicaciones Posoperatorias/terapia , Prevalencia
2.
Clin Nutr ; 32(3): 396-403, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22981598

RESUMEN

BACKGROUND & AIMS: Long-term home parenteral nutrition (HPN) may cause distress and negatively affect quality of life (QoL). The HPN version of the Distress Thermometer and Problem List (DT/PL) was developed to evaluate distress during HPN. This study validates the DT/PL, examines referral wish for additional care, assesses opinions on the DT/PL, and studies risk factors for distress and referral wish. METHODS: Dutch and Scottish patients completed questions on socio-demographic and HPN-related general characteristics, the DT/PL, referral wish, the Hospital Anxiety and Depression Scale, and opinions on the DT. RESULTS: The HPN version of the DT/PL seemed valid and the PL sufficiently reliable. Cut-off score appeared to be 6. Consequently, 45% of patients were diagnosed as clinically distressed. Fifty-three percent had a referral wish. Emotional and physical problems were most strongly associated with distress. Not being able to work related to elevated distress. Female gender and co-morbidity related to referral wish. Opinions on the DT were generally positive. CONCLUSION: The DT/PL appears to be a good instrument to regularly gain insight into distress and referral wish in HPN patients. Use of the DT/PL facilitates support to patients who most need and want it, thus improving quality of care and QoL.


Asunto(s)
Trastornos de Ansiedad/diagnóstico , Tamizaje Masivo , Nutrición Parenteral en el Domicilio/efectos adversos , Derivación y Consulta , Estrés Psicológico/diagnóstico , Adulto , Anciano , Trastornos de Ansiedad/etiología , Trastornos de Ansiedad/psicología , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Escalas de Valoración Psiquiátrica , Calidad de Vida , Factores de Riesgo , Factores Socioeconómicos , Estrés Psicológico/etiología , Estrés Psicológico/psicología , Encuestas y Cuestionarios , Adulto Joven
3.
Int J Colorectal Dis ; 27(8): 1095-9, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22302593

RESUMEN

PURPOSE: This study aims to provide an overview of all complications that may occur after construction of an ileostomy or colostomy (loop or end) in daily practice. METHODS: Between July 2007 and April 2008, all adult patients who underwent any type of intestinal stoma formation were asked to participate in this prospective cohort study. All relevant patient characteristics were gathered.Patients were evaluated for complications eight times in a1-year postoperative period. Enterostomal therapy nurses scored complications on specially designed forms. RESULTS: One hundred patients were included; two patients were lost before initial follow-up (FU). During FU, 21% of the patients deceased, and 15% were lost, physically unable to visit the outpatient clinic or withdrew from FU. In 37% of the patients, bowel continuity was restored. Only 26% of the patients were able to complete FU. Overall, 82% of all the patients had one or more stoma-related complications. Most common complications were skin irritation (55%), fixation problems (46%) and leakage (40%). Superficial necrosis,bleeding and retraction occurred in 20%, 14% and 9% of patients, respectively. More stoma related complications were found in stoma's on inappropriate locations. CONCLUSIONS: In this heterogenic patient population with formation of different stoma types, a high complication rate was detected.


Asunto(s)
Complicaciones Posoperatorias/etiología , Estomas Quirúrgicos/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Admisión del Paciente , Estudios Prospectivos , Adulto Joven
4.
Int J Antimicrob Agents ; 23(5): 506-9, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15120732

RESUMEN

Management of urinary tract infections (UTI) in Central America and especially Nicaragua, is complicated by the lack of knowledge about the antibiotic resistance of uropathogens. We conducted a prevalence study to gain more insight into the aetiology, bacterial resistance and risk factors for symptomatic UTI in the region of León, Nicaragua. In 2002, all consecutive patients with UTI symptoms and pyuria >/=10 WBC/hpf were admitted to the study. Positive cultures from midstream urine specimens were defined as >/=10(5) cfu/ml of a single uropathogen. Susceptibility tests were performed with disc diffusion tests using the Kirby-Bauer method and broth microdilution using National Committee for Clinical Laboratory Standards criteria both in León and a reference laboratory in Utrecht. A positive culture was present in 62 of 208 study subjects (30%). Escherichia coli (56%), Klebsiella spp. (18%) and Enterobacter spp. (11%) were the most frequent pathogens isolated. Presence of cystocele, incontinence and increasing age were risk factors for bacterial UTI. E. coli was least resistant to ceftriaxone, amikacin and nitrofurantoin (>90% susceptible). We observed high resistance rates in E. coli to amoxicillin (82%, MIC(90) 128 mg/l), trimethoprim-sulphamethoxazole (TMP-SMX) (64%, MIC(90) 32 mg/l), cephalothin (58%, MIC(90), 32 mg/l), ciprofloxacin (30%; MIC(90), 32 mg/l), amoxicillin/clavulanate (21%, MIC(90) 8 mg/l) and gentamicin (12%, MIC(90) 2 mg/l). Our results suggests that community acquired uropathogens in Nicaragua are highly resistant to many antimicrobial agents. The use of amoxicillin, trimethoprim-sulphamethoxazole and cephalothin against uropathogens needs to be reconsidered. High quinolone resistance rates among E. coli in Nicaragua gives cause for great concern.


Asunto(s)
Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Bacterias/aislamiento & purificación , Infecciones Urinarias/microbiología , Adulto , Amoxicilina/farmacología , Amoxicilina/uso terapéutico , Cefalotina/farmacología , Cefalotina/uso terapéutico , Combinación de Medicamentos , Farmacorresistencia Bacteriana , Enterobacter/efectos de los fármacos , Enterobacter/aislamiento & purificación , Escherichia coli/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Femenino , Humanos , Klebsiella/efectos de los fármacos , Klebsiella/aislamiento & purificación , Masculino , Pruebas de Sensibilidad Microbiana , Nicaragua , Piuria/microbiología , Quinolonas/farmacología , Quinolonas/uso terapéutico , Factores de Riesgo , Sulfametizol/farmacología , Sulfametizol/uso terapéutico , Trimetoprim/farmacología , Trimetoprim/uso terapéutico , Enfermedades de la Vejiga Urinaria , Incontinencia Urinaria , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/epidemiología , Orina/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...